Compare CF Industries Holdings, Inc. (CF) vs Incyte Corporation (INCY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CF Industries Holdings, Inc. vs Incyte Corporation — how do they compare? CF Industries Holdings, Inc. trades at $117.34 (market cap $17.83B), while Incyte Corporation trades at $120.45 (market cap $24.54B). The key difference: Incyte Corporation is the larger of the two by market cap, and CF Industries Holdings, Inc. pays a 2.04% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| CF | INCY | |
|---|---|---|
Market Cap | $17.83B | $24.54B |
Sector | Basic Materials | Health |
52-Week High | $137.55 | $129.93 |
52-Week Low | $76.08 | $81.61 |
Enterprise Value | $18.96B | $20.04B |
Dividend Yield | 2.04% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About CF Industries Holdings, Inc.
CF Industries is a leading producer and distributor of nitrogen fertilizers. The company operates seven nitrogen facilities in North America and holds joint venture interests in further production capacity in the United Kingdom and Trinidad and Tobago. CF makes nitrogen primarily using low-cost U.S. natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally.
Read more on CF →About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →
